Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic N-acetylcysteine to prevent cisplatin-induced ototoxicity
2019-004463-44Phase 4Terminated
- Sponsor
- Saint-Pierre University Hospital
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of acetylcysteine in ototoxicity, sponsored by Saint-Pierre University Hospital. Primary endpoint: Incidence of ototoxicity (CTCAE v5). Started Nov 2019; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
ototoxicity
Beyond the preview
Go deeper on 2019-004463-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004463-44.